Department of Pediatrics, Faculty of Medicine, Assiut University, Assiut, Egypt.
Department of Clinical Pathology, Faculty of Medicine, Aswan University, Aswan, Egypt.
Arch Endocrinol Metab. 2023 Mar 30;67(3):395-400. doi: 10.20945/2359-3997000000597. Epub 2023 Feb 7.
To assess serum anti-Müllerian hormone (AMH) levels as an ovarian reserve marker in adolescent girls with autoimmune thyroiditis (AIT) and explore the relationship of this marker with autoimmunity and thyroid function biomarkers.
This study included 96 adolescent girls with newly diagnosed AIT and 96 healthy, age- and sex-matched controls. All participants were evaluated with detailed history taking and physical examination, thyroid ultrasound, and measurement of levels of thyroid-stimulating hormone (TSH), free thyroxin (FT4), free triiodothyronine (FT3), antithyroid peroxidase antibodies (TPOAb), antithyroglobulin antibody (TGAb), estradiol, total testosterone, and anti-Müllerian hormone (AMH) levels. The LH/FSH ratio was also calculated. Among 96 patients evaluated, 78 were overtly hypothyroid and 18 were euthyroid. AMH levels were significantly lower in participants with overt hypothyroidism and euthyroidism compared with controls.
Serum levels of AMH correlated negatively with age, body mass index (BMI) standard deviation score (SDS), and TPOAb, TGAb, and TSH levels but positively with FT4 levels. In multivariate analysis, AMH levels correlated significantly with age (odds ratio [OR] = 1.65, 95% confidence interval [CI] 1.18-2.32, p = 0.05), BMI SDS (OR = 2.3, 95% CI, 2.23-3.50, p = 0.01), TSH (OR = 2.43, 95% CI 1.5-2.8, p = 0.01), and TPOAb (OR = 4.1, 95% CI 3.26-8.75, p = 0.001).
Ovarian reserve of adolescent girls with AIT, as measured by serum AMH levels, is affected by thyroid autoimmunity and hypothyroidism, indicating a possible need for ovarian reserve monitoring in these patients.
评估血清抗苗勒管激素(AMH)水平作为青春期自身免疫性甲状腺炎(AIT)患者卵巢储备标志物,并探讨该标志物与自身免疫和甲状腺功能生物标志物的关系。
本研究纳入了 96 例新诊断的 AIT 青春期女孩和 96 例年龄和性别匹配的健康对照者。所有参与者均接受详细的病史采集和体格检查、甲状腺超声检查以及促甲状腺激素(TSH)、游离甲状腺素(FT4)、游离三碘甲状腺原氨酸(FT3)、甲状腺过氧化物酶抗体(TPOAb)、甲状腺球蛋白抗体(TGAb)、雌二醇、总睾酮和抗苗勒管激素(AMH)水平的检测。还计算了黄体生成素/卵泡刺激素(LH/FSH)比值。在 96 例评估者中,78 例为明显甲状腺功能减退,18 例为甲状腺功能正常。与对照组相比,明显甲状腺功能减退和甲状腺功能正常的患者血清 AMH 水平显著降低。
血清 AMH 水平与年龄、体重指数(BMI)标准差评分(SDS)、TPOAb、TGAb 和 TSH 水平呈负相关,与 FT4 水平呈正相关。多变量分析显示,AMH 水平与年龄(比值比 [OR] = 1.65,95%置信区间 [CI] 1.18-2.32,p = 0.05)、BMI SDS(OR = 2.3,95%CI,2.23-3.50,p = 0.01)、TSH(OR = 2.43,95%CI 1.5-2.8,p = 0.01)和 TPOAb(OR = 4.1,95%CI 3.26-8.75,p = 0.001)显著相关。
AIT 青春期女孩的卵巢储备功能,通过血清 AMH 水平来衡量,受到甲状腺自身免疫和甲状腺功能减退的影响,这表明这些患者可能需要进行卵巢储备监测。